carvedilol has been researched along with lypressin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berzigotti, A; Bosch, J | 1 |
| Arlt, J; Dahmen, U; Dirsch, O; Homeyer, A; Settmacher, U; Wei, W; Xie, C | 1 |
1 review(s) available for carvedilol and lypressin
| Article | Year |
|---|---|
Pharmacologic management of portal hypertension.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-Antagonists; Angiogenesis Inhibitors; Anti-Bacterial Agents; Antihypertensive Agents; Antioxidants; Carbazoles; Carvedilol; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Portal; Liver Circulation; Lypressin; Portal Pressure; Propanolamines; Renin-Angiotensin System; Somatostatin; Splanchnic Circulation; Terlipressin; Vascular Resistance; Vasodilator Agents | 2014 |
1 other study(ies) available for carvedilol and lypressin
| Article | Year |
|---|---|
Modulation of hepatic perfusion did not improve recovery from hepatic outflow obstruction.
Topics: Animals; Antihypertensive Agents; Carbazoles; Carvedilol; Hepatectomy; Isosorbide Dinitrate; Liver; Lypressin; Male; Octreotide; Portal Pressure; Propanolamines; Rats, Inbred Lew; Sildenafil Citrate; Splenectomy; Terlipressin; Vasoconstrictor Agents; Vasodilator Agents | 2017 |